Cargando…

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

IMPORTANCE: Suboptimal adherence to endocrine therapy (ET) among patients with hormone-receptor–positive breast cancer significantly affects survival outcomes and is associated with higher hospitalization rates and health care costs. Weak adherence to long-term treatments has multiple determinants,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rassy, Elie, Bardet, Aurélie, Bougacha, Omar, Gantzer, Laurène, Lekens, Béranger, Delaloge, Suzette, André, Fabrice, Michiels, Stefan, Pistilli, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719053/ https://www.ncbi.nlm.nih.gov/pubmed/36459136 http://dx.doi.org/10.1001/jamanetworkopen.2022.44849

Ejemplares similares

Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer
por: Giudici, Fabiola, et al.
Publicado: (2023)

Changes in the use of psychotropic drugs during the course of Alzheimer's disease: A large‐scale longitudinal study of French medical records
por: Ansart, Manon, et al.
Publicado: (2021)

Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
por: Grinda, Thomas, et al.
Publicado: (2023)

Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead
por: Grinda, Thomas, et al.
Publicado: (2023)

Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
por: Rassy, Elie, et al.
Publicado: (2022)

Prescription of antibiotics by general practitioners for patients with a diagnosis of SARS- CoV-2 infection: Analysis of an electronic French health record
por: Diamantis, Sylvain, et al.
Publicado: (2023)

Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study
por: Ferrières, Jean, et al.
Publicado: (2021)

Can Precision Oncology Benefit Patients With Cancers of Unknown Primary?
por: Rassy, Elie, et al.
Publicado: (2023)

Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France
por: Charles, Cécile, et al.
Publicado: (2022)

Costs of Prescription Drugs for Children and Parental Adherence to Long-Term Medications
por: Lauffenburger, Julie C., et al.
Publicado: (2023)

Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
por: Carausu, Marcela, et al.
Publicado: (2022)

Association of Endocrine Therapy Initiation Timeliness With Adherence and Continuation in Low-Income Women With Breast Cancer
por: Sood, Nikita, et al.
Publicado: (2022)

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up
por: Veron, Lucie, et al.
Publicado: (2021)

Impact of deintensifying hypoglycaemic drugs in older adults with type 2 diabetes: protocol for an emulation of a target trial
por: Christiaens, Antoine, et al.
Publicado: (2023)

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
por: Pistilli, Barbara, et al.
Publicado: (2020)

Impact of COVID-19 on healthcare organisation and cancer outcomes
por: Bardet, Aurelie, et al.
Publicado: (2021)

Clinical development of mTOR inhibitors in breast cancer
por: Vicier, Cecile, et al.
Publicado: (2014)

Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer
por: Hu, Xin, et al.
Publicado: (2022)

Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis()()
por: Zhao, Jun, et al.
Publicado: (2019)

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
por: Carbonnier, Vincent, et al.
Publicado: (2023)

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies
por: Tay-Teo, Kiu, et al.
Publicado: (2019)

Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions
por: Beckett, Robert D., et al.
Publicado: (2019)

Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse
por: Beckett, Robert D., et al.
Publicado: (2020)

Drug Resistance Evolution in HIV in the Late 1990s: Hard Sweeps, Soft Sweeps, Clonal Interference and the Accumulation of Drug Resistance Mutations
por: Williams, Kadie-Ann, et al.
Publicado: (2020)

Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic
por: Bizot, Alexandra, et al.
Publicado: (2021)

Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care
por: Di Meglio, Antonio, et al.
Publicado: (2022)

Tumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system
por: Feunteun, Jean, et al.
Publicado: (2022)

Evaluation of adverse drug reaction formatting in drug information databases
por: McConachie, Sean M., et al.
Publicado: (2020)

Associations of Bariatric Interventions With Micronutrient and Endocrine Disturbances
por: Syn, Nicholas L., et al.
Publicado: (2020)

Severe cutaneous reactions to drugs in the setting of a general hospital
por: Grando, Luciana Rosa, et al.
Publicado: (2014)

Miniature Short Hairpin RNA Screens to Characterize Antiproliferative Drugs
por: Kittanakom, Saranya, et al.
Publicado: (2013)

Pharmacology of the endocrine system and related drugs: progesterone, progestational drugs and antifertility agents.
Publicado: (1971)

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis
por: Vaz-Luis, Ines, et al.
Publicado: (2022)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children
por: Midya, Vishal, et al.
Publicado: (2022)

Adverse drug reactions in drug information databases: does presentation affect interpretation?
por: McConachie, Sean M., et al.
Publicado: (2020)

Evaluation of adverse drug reaction formatting in drug information mobile phone applications
por: McConachie, Sean M., et al.
Publicado: (2022)

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016)

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016)

Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3l4mbbrrplol6od7kpv82oc1d0